Filing Flows › Companies › Conmed › Timeline
Conmed stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+16.5% to $51.50
Conmed (CNMD) stock rose 17% over the last 252 sessions, to $51.50. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 6 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Oct 28, 2026 | Earnings | Earnings: beat the EPS estimate by 3.7% | −3.1% (−3.4% vs SPY) | 0.0% (+2.1% vs SPY) | — |
| Jul 29, 2026 | Earnings | Earnings: beat the EPS estimate by 24.3% | −2.4% (−0.8% vs SPY) | +13.0% (+9.0% vs SPY) | +13.2% (+9.8% vs SPY) |
| Jun 17, 2026 | 8-K | Directors and officers: departures, appointments, pay | +1.4% (+0.4% vs SPY) | +7.4% (+8.0% vs SPY) | +30.2% (+29.8% vs SPY) |
| Jun 4, 2026 | 8-K | Material definitive agreement | +6.1% (+5.7% vs SPY) | +9.4% (+13.2% vs SPY) | +6.0% (+6.1% vs SPY) |
| Jun 1, 2026 | 8-K | Material definitive agreement | −3.0% (−3.3% vs SPY) | −1.5% (+1.0% vs SPY) | −8.7% (−7.7% vs SPY) |
| May 20, 2026 | 8-K | Directors and officers: departures, appointments, pay | +2.3% (+1.2% vs SPY) | −1.9% (−4.2% vs SPY) | −10.5% (−12.5% vs SPY) |
| Apr 29, 2026 | Earnings | Earnings: beat the EPS estimate by 8.8% | −2.3% (−2.3% vs SPY) | −0.4% (−2.1% vs SPY) | −3.5% (−9.3% vs SPY) |
| Mar 13, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.3% (−0.7% vs SPY) | −3.7% (−1.8% vs SPY) | +6.4% (+1.4% vs SPY) |
| Jan 28, 2026 | Earnings | Earnings: beat the EPS estimate by 8.0% | −2.3% (−2.3% vs SPY) | −2.0% (−1.2% vs SPY) | +14.8% (+15.7% vs SPY) |
| Jan 8, 2026 | 8-K | Directors and officers: departures, appointments, pay | −3.0% (−3.6% vs SPY) | −3.8% (−4.2% vs SPY) | −5.9% (−6.5% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Conmed: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.